Skip to content

Theory development and pilot evaluation of a hierarchical model of integrated health and social care for older people from the perspective of home and community-based care service

Theory development and pilot evaluation of a hierarchical model of integrated health and social care for older people from the perspective of home and community-based care service

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600115981
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes and/or hypertension

Interventions

Control group1:Usual Community Care for Tier 1 and 2 of the integrated healthcare and elderly care model
Intervention group 1:Community Canteen-Based Intervention for Tier 1 and 2 of the integrated healthcare and elderly care model
Intervention group 2:Integrated Online and Senior Meal Service Intervention for Tier 3 and 4 of the integrated healthcare and elderly care model
Control group2:Usual Community Care for Tier 1 and 2 of the integrated healthcare and elderly care model

Sponsors

Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Classification into Tier 1, 2, 3, or 4 of the integrated healthcare and elderly care model: Tier 1: Individuals who meet the following criteria: (1) Have a confirmed diagnosis of type 2 diabetes and/or hypertension, OR exhibit abnormal blood pressure (systolic BP >=140mmHg and/or diastolic BP >=90mmHg) and/or abnormal blood glucose (fasting blood glucose >=7.0mmol/L OR OGTT 2-hour blood glucose >=11.1mmol/L OR HbA1c >=6.5%), OR are currently receiving antihypertensive treatment and/or hypoglycemic treatment; (2)Are capable of self-care; (3) Are aged >=60 years; (4)Are community-dwelling older adults receiving home-based care. Tier 2: Individuals who meet the following criteria: (1) Are older adults requiring medical services during convalescence, at the end-of-life stage, or after hospital discharge; (2)Are capable of self-care; (3) Are aged >=60 years; (4)Are community-dwelling older adults receiving home-based care. Tier 3: Individuals who meet the following criteria: (1) Have a confirmed diagnosis of type 2 diabetes and/or hypertension, OR exhibit abnormal blood pressure (systolic BP >=140mmHg and/or diastolic BP >=90mmHg) and/or abnormal blood glucose (fasting blood glucose >=7.0mmol/L OR OGTT 2-hour blood glucose >=11.1mmol/L OR HbA1c >=6.5%), OR are currently receiving antihypertensive treatment and/or hypoglycemic treatment; (2)Are partially capable of self-care; (3) Are aged >=60 years; (4)Are community-dwelling older adults receiving home-based care. Tier 4: Individuals who meet the following criteria: (1) Are older adults requiring medical services during convalescence, at the end-of-life stage, or after hospital discharge; (2)Are partially capable of self-care; (3) Are aged >=60 years; (4)Are community-dwelling older adults receiving home-based care. 2. Permanent resident of the pilot community (defined as being away from the community for less than one month per year). 3. Able to use a smartphone. 4. Voluntary participation in the study and provision of signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of secondary hypertension or diabetes mellitus. 2. Severe cognitive impairment (e.g., Alzheimer's disease, Vascular dementia, Dementia with Lewy bodies). 3. Concurrent diagnosis of cancer, having undergone radiotherapy or chemotherapy within the past six months. 4. Diagnosis of end-stage diseases where completion of the entire intervention cycle is not anticipated (e.g., end-stage renal disease, end-stage pneumonia, severe heart failure). 5. Severe immune system disorders (e.g., Systemic lupus erythematosus, Immunodeficiency diseases, HIV positive). 6. Individuals with impaired consciousness or severe psychiatric disorders (e.g., Schizophrenia, Major depressive disorder). 7. History of substance abuse or alcohol dependence, or participation in any drug clinical trials within the past year. 8. Current participation in other similar interventional research studies. 9. Unwillingness to participate in this study.

Design outcomes

Primary

MeasureTime frame
Body Mass Index;Waist-to-Hip Ratio;Blood Pressure;

Secondary

MeasureTime frame
Health-related life quality;Health-related behavior;

Countries

China

Contacts

Public ContactXuxi Zhang

Peking University

xuxizhang@bjmu.edu.cn+86 82801519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026